Viemed Healthcare Inc. Common Shares
VMDUnited States
5 filed reports · 197 financial concepts · 4 earnings calls · 0 media appearances
Filed reports
5 reports · Jun 2025 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 4 | 847 | Jun 2025 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 1 | 652 | Dec 2025 |
Financial data
197 concepts · 1,499 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial195 concepts · 1,451 facts · Dec 2023 to Jun 2026
- Stockholders equity including portion attributable to noncontrolling interest14 · Dec 2023 to Jun 2026
- Adjustments related to tax withholding for share based compensation13 · Dec 2023 to Jun 2026
- Adjustments to additional paid in capital share based compensation restricted stock units requisite service period recognition13 · Dec 2023 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents13 · Dec 2023 to Jun 2026
- Profit loss13 · Dec 2023 to Jun 2026
- Stock issued during period value restricted stock award gross13 · Dec 2023 to Jun 2026
- Stock issued during period value stock options exercised13 · Dec 2023 to Jun 2026
- Allocated share based compensation expense12 · Dec 2023 to Jun 2026
- Cost of goods and services sold depreciation12 · Dec 2023 to Jun 2026
- Cost of goods and services sold (US GAAP)12 · Dec 2023 to Jun 2026
- Depreciation and amortization12 · Dec 2023 to Jun 2026
- Gain loss on disposition of assets12 · Dec 2023 to Jun 2026
- Gross profit (US GAAP)12 · Dec 2023 to Jun 2026
- Income tax expense benefit12 · Dec 2023 to Jun 2026
- Net income loss12 · Dec 2023 to Jun 2026
- Net income loss attributable to noncontrolling interest12 · Dec 2023 to Jun 2026
- Operating income loss12 · Dec 2023 to Jun 2026
- Other nonoperating income expense12 · Dec 2023 to Jun 2026
- Research and development expense12 · Dec 2023 to Jun 2026
- Revenue12 · Dec 2023 to Jun 2026
- Selling general and administrative expense12 · Dec 2023 to Jun 2026
- Adjustments to additional paid in capital share based compensation stock options requisite service period recognition11 · Dec 2023 to Dec 2025
- Amortization of financing costs11 · Dec 2023 to Jun 2026
- Asset impairment charges11 · Dec 2023 to Jun 2026
Product2 concepts · 48 facts · Dec 2023 to Jun 2026
- Operating lease lease income24 · Dec 2023 to Jun 2026
- Revenue24 · Dec 2023 to Jun 2026
Segments
48 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or service4 members · 48 facts
- Equipment Sales12 · Dec 2023 to Jun 2026
- Other Durable Medical Equipment Rentals12 · Dec 2023 to Jun 2026
- Service12 · Dec 2023 to Jun 2026
- Ventilator Rental12 · Dec 2023 to Jun 2026
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
4 calls · Nov 2025 to Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 4, 2026
- FY2026 Q1May 6, 2026
- FY2025 Q4Mar 5, 2026
- FY2025 Q3Nov 7, 2025
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.